Timing the initiation of multiple myeloma

Even H. Rustad(Memorial Sloan Kettering Cancer Center), Venkata D. Yellapantula(Memorial Sloan Kettering Cancer Center), Daniel Leongamornlert(Wellcome Sanger Institute), Niccolò Bolli(University of Milan), Guy Ledergor(University of California, San Francisco), Ferran Nadeu(Centro de Investigación Biomédica en Red de Cáncer), Nicos Angelopoulos(Wellcome Sanger Institute), Kevin J. Dawson(Wellcome Sanger Institute), Thomas J. Mitchell(Wellcome Sanger Institute), Robert J. Osborne(Wellcome Sanger Institute), Bachisio Ziccheddu(University of Milan), Cristiana Carniti(Fondazione IRCCS Istituto Nazionale dei Tumori), Vittorio Montefusco(Fondazione IRCCS Istituto Nazionale dei Tumori), Paolo Corradini(University of Milan), Kenneth C. Anderson(Harvard University), Philippe Moreau(Nantes Université), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Ludmil B. Alexandrov(University of California San Diego), Xosé S. Puente(Universidad de Oviedo), Elı́as Campo(Centro de Investigación Biomédica en Red de Cáncer), Reiner Siebert(Universität Ulm), Hervé Avet‐Loiseau(Inserm), Ola Landgren(Memorial Sloan Kettering Cancer Center), Nikhil C. Munshi(Harvard University), Peter J. Campbell(Wellcome Sanger Institute), Francesco Maura(Memorial Sloan Kettering Cancer Center)
Nature Communications
April 21, 2020
Cited by 163Open Access
Full Text

Abstract

Abstract The evolution and progression of multiple myeloma and its precursors over time is poorly understood. Here, we investigate the landscape and timing of mutational processes shaping multiple myeloma evolution in a large cohort of 89 whole genomes and 973 exomes. We identify eight processes, including a mutational signature caused by exposure to melphalan. Reconstructing the chronological activity of each mutational signature, we estimate that the initial transformation of a germinal center B-cell usually occurred during the first 2 nd -3 rd decades of life. We define four main patterns of activation-induced deaminase (AID) and apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC) mutagenesis over time, including a subset of patients with evidence of prolonged AID activity during the pre-malignant phase, indicating antigen-responsiveness and germinal center reentry. Our findings provide a framework to study the etiology of multiple myeloma and explore strategies for prevention and early detection.


Related Papers

No related papers found

Powered by citation graph analysis